<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>15</volume><submitter>Dakik H</submitter><pubmed_abstract>Advances in large-scale proteomics analysis have been very useful in understanding pathogenesis of diseases and elaborating therapeutic strategies. Proteomics has been employed to study Parkinson disease (PD); however, sparse studies reported proteome investigation after cell therapy approaches. In this study, we used liquid chromatography-tandem mass spectrometry and systems biology to identify differentially expressed proteins in a translational mouse model of PD after cell therapy. Proteins were extracted from five nigrostriatal-related brain regions of mice previously lesioned with 6-hydroxydopamine in the substantia nigra. Protein expression was compared in non-grafted brain to 1 and 7 days after intranigral grafting of E12.5 embryonic ventral mesencephalon (VM). We found a total of 2</pubmed_abstract><journal>Frontiers in neuroscience</journal><pagination>621121</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7991918</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Analysis of the Neuroproteome Associated With Cell Therapy After Intranigral Grafting in a Mouse Model of Parkinson Disease.</pubmed_title><pmcid>PMC7991918</pmcid><pubmed_authors>Gaillard A</pubmed_authors><pubmed_authors>Nehme A</pubmed_authors><pubmed_authors>Zibara K</pubmed_authors><pubmed_authors>Prestoz L</pubmed_authors><pubmed_authors>Dakik H</pubmed_authors><pubmed_authors>Mantash S</pubmed_authors><pubmed_authors>Kobeissy F</pubmed_authors><pubmed_authors>Mirzaei P</pubmed_authors><pubmed_authors>Mechref Y</pubmed_authors><pubmed_authors>Zabet-Moghaddam M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Analysis of the Neuroproteome Associated With Cell Therapy After Intranigral Grafting in a Mouse Model of Parkinson Disease.</name><description>Advances in large-scale proteomics analysis have been very useful in understanding pathogenesis of diseases and elaborating therapeutic strategies. Proteomics has been employed to study Parkinson disease (PD); however, sparse studies reported proteome investigation after cell therapy approaches. In this study, we used liquid chromatography-tandem mass spectrometry and systems biology to identify differentially expressed proteins in a translational mouse model of PD after cell therapy. Proteins were extracted from five nigrostriatal-related brain regions of mice previously lesioned with 6-hydroxydopamine in the substantia nigra. Protein expression was compared in non-grafted brain to 1 and 7 days after intranigral grafting of E12.5 embryonic ventral mesencephalon (VM). We found a total of 2</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2026-04-07T21:23:25.178Z</modification><creation>2022-02-09T08:54:40.175Z</creation></dates><accession>S-EPMC7991918</accession><cross_references><pubmed>33776636</pubmed><doi>10.3389/fnins.2021.621121</doi></cross_references></HashMap>